A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
This research study, called CUV105, is investigating a new way to treat vitiligo, a skin condition that causes white patches. Researchers want to see if combining a medication called afamelanotide (given as a small implant under the skin) with a type of light therapy (Narrow-Band Ultraviolet, or NB-UVB light) is more effective and safe than using only NB-UVB light. The study specifically focuses on vitiligo patches on the body and face. This is a Phase 3 trial, meaning it's one of the final steps before a treatment might be made widely available. It's designed to help doctors understand the best ways to help people living with vitiligo.
Auf einen Blick
Worum geht es in dieser Studie?
Vitiligo is a condition where your immune system mistakenly attacks the cells that give your skin its colour (melanocytes), leading to white patches on your skin. This study is exploring a potential new treatment approach. It's called CUV105 and it's looking at whether a combination of treatments could work better than one treatment alone.
The main aim is to see if a small implant containing a medicine called afamelanotide, when used alongside a type of light treatment called Narrow-Band Ultraviolet B (NB-UVB) therapy, can help re-colour the skin patches more effectively and safely than using just the NB-UVB light therapy on its own. NB-UVB therapy is a common treatment for vitiligo, using specific wavelengths of light to stimulate pigment cells.
Researchers will be carefully watching how well people's skin re-pigments (gets its colour back) on both their body and face, and they'll also be checking for any side effects. This study is important because it could lead to better treatment options for people with vitiligo, offering new hope for managing the condition.
Wichtige Erkenntnisse
- The study is testing a new combination treatment for vitiligo.
- It compares an implant plus light therapy against light therapy alone.
- Participation involves regular clinic visits and monitoring.
- You might get the new treatment or the standard treatment.
- It's a chance to access potential new treatments and help medical research.
- Sie können die Teilnahme jederzeit beenden.
Wer könnte berechtigt sein?
To join this study, participants generally need to be 12 years old or older and have been diagnosed with vitiligo that affects a certain amount of their body and face. Your skin type, known as Fitzpatrick skin types III to VI, is also important, which generally means your skin tends to tan easily or is naturally darker.
There are also reasons why someone might not be able to join. For example, if you have very fair skin (Fitzpatrick types I-II) or if you've recently had other light treatments for vitiligo within the last three months. You also can't have certain other skin conditions, a history of skin cancer, or severe liver problems.
For women, you cannot be pregnant or breastfeeding, and if you are able to have children, you must be using effective contraception. Similarly, men with partners who could become pregnant also need to be using effective contraception. These rules are in place to make sure the study is as safe as possible for everyone involved.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie 12 Jahre alt oder älter?
- Do you have white patches from vitiligo on your body and face?
- Does your skin tend to tan easily or is it naturally darker (Fitzpatrick types III-VI)?
- Have you avoided light therapy for vitiligo in the last three months?
- Are you NOT currently pregnant or breastfeeding, and using effective contraception if applicable?
- Do you have any severe liver problems or a history of skin cancer?
Was beinhaltet die Teilnahme?
If you decide to take part in this study, you would either receive the afamelanotide implant along with NB-UVB light therapy, or you would receive only the NB-UVB light therapy. The specific treatment you receive would be decided by chance, like flipping a coin. You would have regular visits to the clinic for assessments, which might include skin examinations, taking photos of your vitiligo patches, and possibly blood tests.
Throughout the study, you'd be carefully monitored for how your vitiligo responds to the treatment and for any side effects you might experience. The afamelanotide implant is a small device inserted under the skin, which would need to be done by a doctor. NB-UVB light therapy usually involves attending a clinic for short sessions a few times a week. The exact number of visits, assessments, and the total duration would be explained in detail by the study team, but typically, these kinds of studies can last for several months to over a year, followed by a follow-up period.
Potenzielle Risiken und Vorteile
Locations (30)
- CLINUVEL siteVerifizierte PostleitzahlBirmingham, Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlFresno, Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlLos Angeles, Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlPalo Alto, Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlSan Diego, Vereinigte Staaten
- CLINUVEL SiteVerifizierte PostleitzahlWashington D.C., Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlMiami, Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlMiramar, United States
- CLINUVEL siteVerifizierte PostleitzahlAlpharetta, United States
- CLINUVEL siteVerifizierte PostleitzahlAugusta, United States
- CLINUVEL siteVerifizierte PostleitzahlChicago, Vereinigte Staaten
- CLINUVEL siteVerifizierte PostleitzahlBaton Rouge, United States
Häufige Fragen
Was ist Vitiligo?
Vitiligo is a long-term skin condition where patches of skin lose their colour, appearing as white spots. This happens when the cells that make skin pigment stop working or are destroyed.
What is NB-UVB light therapy?
NB-UVB light therapy is a common treatment for vitiligo. It uses a special type of ultraviolet light to stimulate pigment-producing cells in the skin to help bring back some colour.
What is afamelanotide?
Afamelanotide is a medicine given as a small implant under the skin. It's being studied to see if it can help stimulate pigment cells and work with light therapy to treat vitiligo.
Will I definitely get the new treatment if I join?
No, participants are randomly assigned to either receive the new treatment combination (afamelanotide + NB-UVB) or the standard treatment (NB-UVB alone). You won't get to choose which group you are in.
Wie lange dauert die Studie?
The full duration of the study, including treatment and follow-up, will be explained in detail by the study team. It typically involves regular visits over several months to over a year.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.